The national search for Palm Beach State College’s nursing director has ended internally with the appointment of Dr. Deborah Copeland, a longtime professor with experience working in clinical roles as a practitioner and administrator.

MORE “COPELAND APPOINTED PBSC NURSING DIRECTOR”

Since her arrival at Palm Beach State College in 2009, Dr. Becky Mercer has been a staunch advocate of STEM (Science, Technology, Engineering and Math).

MORE “MERCER TO BE HONORED FOR ADVANCING STEM EDUCATION”

West Palm Beach, Fla. (Sept. 21, 2018) – Palm Beach County’s unemployment rate for August is 3.9 percent, down from 4.4 percent a year ago. The county’s rate matched the national rate and edged the state’s 3.8 percent rate (all numbers not seasonally adjusted), according to the latest monthly reports released today from CareerSource Palm Beach County and the Florida Department of Economic Opportunity.

MORE “PALM BEACH COUNTY UNEMPLOYMENT RATE DROPS TO 3.9 PERCENT FROM 4.4 PERCENT YEAR AGO; CONSTRUCTION CONTINUES TO LEAD JOB GAINS”

A new four-year, $3 million grant will enable Scripps Research scientists to advance compounds that may protect neurons in diseases caused by toxic protein accumulation, including Parkinson’s, ALS, Alzheimer’s and Creutzfeldt-Jakob disease.

MORE “POTENTIAL DRUGS FOR ALS, ALZHEIMER’S AND PARKINSON’S GARNER $3 MILLION GRANT”

BOCA RATON, Fla.–(BUSINESS WIRE)–TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced the commercial availability of Imvexxy™ (estradiol vaginal inserts) 4 mcg dose in the United States. Imvexxy 4mcg is the lowest dose vaginal estrogen product approved by the U.S. Food and Drug Administration (FDA) for treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Imvexxy is the only product in its therapeutic class to offer a 4 mcg and 10 mcg dose, the 4 mcg representing the lowest approved dose of vaginal estradiol available.

MORE “THERAPEUTICSMD ANNOUNCES COMMERCIAL AVAILABILITY OF IMVEXXY™ 4 MCG”

How is it that you can have too much hair on some places of your body while not enough on others? Seems a little unfair not to mention frustrating, right? After trying out a low-level light therapy helmet with success to combat my own hair loss, which I will chalk up to stress, I decided to go further down the rabbit hole and try out a different light-based device—the Hairmax LaserBand 82, an FDA cleared device that delivers low-level laser therapy to slow hair loss while also stimulating new hair growth. What drew me to this device was unlike my other one the Hairmax device did not require an electrical outlet during use and the treatment time was 90 seconds every other day versus 25 minutes every other day.

MORE “HAIRMAX OFFERS HAIR LOSS SUFFERERS THE FASTEST LOW-LEVEL LASER TREATMENT ON THE MARKET”

Do you hate going to the dentist? The needles and the pain — no fun. Now, there’s new laser technology that’s helping dentists ditch the drills and giving patients a reason to smile.’ MORE “DENTISTS USING LASER TECHNOLOGY WITH NO NEEDLES OR DRILL”

Boca Raton-based TherapeuticsMD began distributing its new product, Imvexxy, to stores recently. It will be available at all major retailers such as CVS, Walgreens and Walmart, as well as small pharmacies.

MORE “NEW TREATMENT FOR MENOPAUSAL WOMEN ON ITS WAY TO PHARMACIES”

Sensus Healthcare (NSDQ:SRTSU) today priced an upcoming offering looking to raise approximately $15 million to help support development of its superficial radiation therapy devices.

MORE “SENSUS HEALTHCARE PRICES $15M OFFERING”

Young people entering the work force are lacking both the technical and soft skills they need to succeed in the workplace, according to a study released Thursday by the Business Development Board of Palm Beach County.

MORE “PALM BEACH COUNTY LOOKS TO IMPROVE YOUTH TRAINING, SKILLS FOR FUTURE WORK FORCE”